Literature DB >> 6331417

Kinetic and e.p.r. studies of cyanide and azide binding to the copper sites of dopamine (3,4-dihydroxyphenethylamine) beta-mono-oxygenase.

N J Blackburn, D Collison, J Sutton, F E Mabbs.   

Abstract

The kinetics of inhibition of dopamine (3,4-dihydroxyphenethylamine) beta-mono-oxygenase by cyanide (CN-) and azide (N3-) ions have been investigated by using steady-state methods. Both anions show complex non-competitive-inhibition patterns with respect to ascorbate, suggestive of anion binding at two different sites on the oxidized enzyme. To further investigate this finding, e.p.r. titrations of CN- and N3- binding to the 63Cu-reconstituted enzyme were carried out. Addition of approx. 2 equiv. of CN- to copper elicits a new signal with g = 2.217, g = 2.025, A = 17.0 mT characteristic of a copper (II)-cyano complex. Simulations show that this signal accounts for half the copper (II) in the enzyme. The remainder of the enzyme-bound copper is expressed by a signal close to, but not identical with, that of native enzyme. Further addition of CN- induces a simultaneous decrease in intensity of both of these signals so that their 1:1 ratio is maintained. Binding of N3-, on the other hand, changes the e.p.r. spectrum to a form different from either that of the native or CN- -treated enzyme, and integrates to 100% of the copper in the enzyme (g = 2.252, g = 2.050, A = 16.5 mT). Resolved superhyperfine structure is apparent in the g region. N3- binding is also accompanied by the appearance of a broad charge-transfer band centred at 387 nm. Neither 9 nor 35 GHz e.p.r. spectra show evidence for more than one (non-interacting) species of Cu(II) in native enzyme and N3- derivatives. The binding and reactivity of CN-, on the other hand, argues against independent copper sites in the enzyme.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331417      PMCID: PMC1153646          DOI: 10.1042/bj2200447

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Purification and characterization of dopamine beta-hydroxylase from bovine adrenal medulla.

Authors:  T Ljones; T Skotland; T Flatmark
Journal:  Eur J Biochem       Date:  1976-01-15

2.  An investigation of the copper site(s) of dopamine-beta-hydroxylase by electron paramagnetic resonance.

Authors:  G A Walker; H Kon; W Lovenberg
Journal:  Biochim Biophys Acta       Date:  1977-06-10

3.  Stereoelectronic properties of metalloenzymes. II. Effects of ligand coordination on the electron spin resonance spectrum of galactose oxidase as a probe of structure and function.

Authors:  R S Giordano; R D Bereman; D J Kosman; M J Ettinger
Journal:  J Am Chem Soc       Date:  1974-02-20       Impact factor: 15.419

4.  Studies of the metal sites of copper proteins. Symmetry of copper in bovine superoxide dismutase and its functional significance.

Authors:  G Rotilio; L Morpurgo; C Giovagnoli; L Calabrese; B Mondovì
Journal:  Biochemistry       Date:  1972-05-23       Impact factor: 3.162

5.  Anion binding to bovine erythrocyte superoxide dismutase. Evidence for multiple binding sites with qualitatively different properties.

Authors:  J A Fee; B P Gaber
Journal:  J Biol Chem       Date:  1972-01-10       Impact factor: 5.157

6.  Electron spin resonance of metallocarbonic anhydrases.

Authors:  J S Taylor; J E Coleman
Journal:  J Biol Chem       Date:  1971-11-25       Impact factor: 5.157

7.  Effect of azide on some spectral and kinetic properties of pig-plasma benzylamine oxidase.

Authors:  A Lindström; B Olsson; G Petterson
Journal:  Eur J Biochem       Date:  1974-10-01

8.  Kinetic studies of the enzymatic dopamine beta-hydroxylation reaction.

Authors:  M Goldstein; T H Joh; T Q Garvey
Journal:  Biochemistry       Date:  1968-08       Impact factor: 3.162

9.  Inhibition of enzymes by metal ion-chelating reagents. Theory and new graphical methods of study.

Authors:  W G Bardsley; R E Childs
Journal:  Biochem J       Date:  1974-01       Impact factor: 3.857

10.  Cu (II)-carbon bonding in cyanide complexes of copper enzymes. 13C splitting of the Cu(II) electron spin resonance.

Authors:  P H Haffner; J E Coleman
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

View more
  6 in total

1.  Reactive airway dysfunction syndrome due to sodium azide inhalation.

Authors:  J S Weiss
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

2.  A continuous-wave electron-nuclear double resonance (X-band) study of the Cu2+ sites of particulate methane mono-oxygenase of Methylococcus capsulatus (strain M) in membrane and pure dopamine beta-mono-oxygenase of the adrenal medulla.

Authors:  Bettina Katterle; Rudolf I Gvozdev; Ntei Abudu; Torbjørn Ljones; K Kristoffer Andersson
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

3.  Differential reactivity between two copper sites in peptidylglycine α-hydroxylating monooxygenase.

Authors:  Eduardo E Chufán; Sean T Prigge; Xavier Siebert; Betty A Eipper; Richard E Mains; L Mario Amzel
Journal:  J Am Chem Soc       Date:  2010-11-10       Impact factor: 15.419

4.  Rational Design of a Histidine-Methionine Site Modeling the M-Center of Copper Monooxygenases in a Small Metallochaperone Scaffold.

Authors:  Katherine B Alwan; Evan F Welch; Renee J Arias; Ben F Gambill; Ninian J Blackburn
Journal:  Biochemistry       Date:  2019-06-27       Impact factor: 3.162

5.  Direct structural information for the copper site of dopamine beta-mono-oxygenase obtained by using extended X-ray-absorption fine structure.

Authors:  S S Hasnain; G P Diakun; P F Knowles; N Binsted; C D Garner; N J Blackburn
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

6.  Reconstitution of Formylglycine-generating Enzyme with Copper(II) for Aldehyde Tag Conversion.

Authors:  Patrick G Holder; Lesley C Jones; Penelope M Drake; Robyn M Barfield; Stefanie Bañas; Gregory W de Hart; Jeanne Baker; David Rabuka
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.